Regulation of kidney-Specific Gene Expression

肾脏特异性基因表达的调节

基本信息

  • 批准号:
    7988995
  • 负责人:
  • 金额:
    $ 9.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-12-07 至 2011-12-06
  • 项目状态:
    已结题

项目摘要

The overall goal of this project is to understand the roles of hepatocyte nuclear factor-13 (HNF-1(3)in kidney-specific gene expression, renal cell differentiation, and kidney organogenesis. HNF-1(3belongs to a family of homeodomain-containing transcription factors that regulate tissue-specific gene expression in the kidney, liver, pancreas, and other organs. Humans with mutations of HNF-13 develop maturity-onset diabetes of the young type 5 (MODY5) and congenital cystic abnormalities of the kidney. Transgenic mice expressing mutant HNF-13 under the control of a kidney-specific promoter develop kidney cysts and renal failure, which is similar to the phenotype of humans with MODY5. Similarly, kidney-specific deletion of HNF- 1(3 using Cre/loxP recombination results in renal cyst formation. HNF-1{3mutant mice show decreased expression of Pkhdl, the gene mutated in autosomal recessive polycystic kidney disease (ARPKD), and HNF-13 directly regulates the Pkhdl promoter. These studies identify Pkhdl as a novel gene target of HNF- 13 in the kidney. They establish a previously unrecognized link between two renal cystic diseases, MODY5 and ARPKD, and suggest that the mechanism of cyst formation in humans with MODY5 involves down- regulation of PKHD1 gene expression. To test this hypothesis and to further define the functions of HNF-13 in the kidney, we will complete the following specific aims: 1. Define the roles of coactivators and histone acetylation in the regulation of Pkhdl gene transcription. 2. Determine how the activity of HNF-13 is reciprocally regulated by SUMO ligases and ubiquitin ligases. 3. Determine how HNF-13 regulates the tissue-specific expression of Pkhdl in the kidney and liver. 4. Elucidate the molecular pathogenesis of the kidney and genitourinary tract abnormalities caused by mutations of HNF-13. The proposed studies will utilize genetically-modified mice to define in vivo expression patterns and disease phenotypes and biochemical studies to elucidate molecular mechanisms. Understanding the functions of HNF-13 and the regulation of Pkhdl gene transcription will provide insights into the pathogenesis of congenital kidney abnormalities and ARPKD,which is one of the most common genetic causes of renal failure in infants and children.
本项目的总体目标是了解肝细胞核因子-13 (HNF-1(3))在肝癌中的作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Igarashi其他文献

Peter Igarashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Igarashi', 18)}}的其他基金

Regulation of Kidney-Specific Gene Expression
肾脏特异性基因表达的调节
  • 批准号:
    10629391
  • 财政年份:
    2022
  • 资助金额:
    $ 9.26万
  • 项目类别:
Regulation of Kidney-Specific Gene Expression
肾脏特异性基因表达的调控
  • 批准号:
    10743246
  • 财政年份:
    2022
  • 资助金额:
    $ 9.26万
  • 项目类别:
Regulation of Kidney-Specific Gene Expression
肾脏特异性基因表达的调节
  • 批准号:
    9318506
  • 财政年份:
    2016
  • 资助金额:
    $ 9.26万
  • 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
  • 批准号:
    7832043
  • 财政年份:
    2009
  • 资助金额:
    $ 9.26万
  • 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
  • 批准号:
    7936337
  • 财政年份:
    2009
  • 资助金额:
    $ 9.26万
  • 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
  • 批准号:
    7883980
  • 财政年份:
    2009
  • 资助金额:
    $ 9.26万
  • 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
  • 批准号:
    8148016
  • 财政年份:
    2007
  • 资助金额:
    $ 9.26万
  • 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
  • 批准号:
    8097975
  • 财政年份:
    2007
  • 资助金额:
    $ 9.26万
  • 项目类别:
UT southwestern O'Brien Kidney Research Core Center
德克萨斯大学西南奥布莱恩肾脏研究核心中心
  • 批准号:
    8912182
  • 财政年份:
    2007
  • 资助金额:
    $ 9.26万
  • 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
  • 批准号:
    7480286
  • 财政年份:
    2007
  • 资助金额:
    $ 9.26万
  • 项目类别:

相似海外基金

Investigation of urinary extracellular vesicles as novel and safe therapeutics for autosomal recessive polycystic kidney disease
尿细胞外囊泡作为常染色体隐性遗传性多囊肾病的新型安全疗法的研究
  • 批准号:
    10750704
  • 财政年份:
    2023
  • 资助金额:
    $ 9.26万
  • 项目类别:
Molecular pathogenesis of autosomal recessive polycystic kidney disease (ARPKD): Fibrocystin as a regulator of cell metabolism and mitochondrial function
常染色体隐性多囊肾病 (ARPKD) 的分子发病机制:纤维囊肿蛋白作为细胞代谢和线粒体功能的调节剂
  • 批准号:
    430863862
  • 财政年份:
  • 资助金额:
    $ 9.26万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了